These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy. Cibere J; Sibley JT; Haga M J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854 [TBL] [Abstract][Full Text] [Related]
26. Controversies, dilemmas, and dialogues. What do you recommend for prophylaxis in an elderly woman with arthritis requiring NSAIDs for control? Jones MP; Schubert ML; Smith JL Am J Gastroenterol; 1991 Mar; 86(3):264-8. PubMed ID: 1900141 [No Abstract] [Full Text] [Related]
27. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy? Wu CS; Wang SH; Chen PC; Wu VC Int J Clin Pract; 1998 Oct; 52(7):472-4. PubMed ID: 10622088 [TBL] [Abstract][Full Text] [Related]
28. Protection of the gastric mucosa from NSAIDs. Fenn GC N Z Med J; 1992 Oct; 105(944):436. PubMed ID: 1297946 [No Abstract] [Full Text] [Related]
29. [Digestive and extra-digestive complications of nonsteroidal anti-inflammatory drugs. Preventive and curative strategies]. Sternon J; Adler M Rev Med Brux; 1997 Apr; 18(2):52-8. PubMed ID: 9221462 [TBL] [Abstract][Full Text] [Related]
30. Prophylaxis at what cost? The debate continues. Robinson AB; Clement DJ Am J Gastroenterol; 1994 Aug; 89(8):1264-6. PubMed ID: 8053452 [No Abstract] [Full Text] [Related]
32. Prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions: a commentary on the new data. Lanza FL Am J Med; 1998 Mar; 104(3A):75S-78S; discussion 79S-80S. PubMed ID: 9572325 [No Abstract] [Full Text] [Related]
33. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data. Talley NJ Am J Med; 1998 Mar; 104(3A):62S-66S; discussion 79S-80S. PubMed ID: 9572323 [No Abstract] [Full Text] [Related]
35. Nonsteroidal anti-inflammatory drug use in dentistry: gastrointestinal implications. Nguyen AM; Graham DY; Gage T; Griffiths GR Gen Dent; 1999; 47(6):590-6; quiz 597-8. PubMed ID: 10687453 [TBL] [Abstract][Full Text] [Related]
37. The development of clinical practice guidelines for treatment of peptic acid diseases in a VA ambulatory care clinic--a comment. Holt RJ; Fort J Pharmacotherapy; 1996; 16(3):480-1; discussion 482-3. PubMed ID: 8726612 [No Abstract] [Full Text] [Related]
38. [Prevention of gastroduodenal disorders due to non-steroidal anti-inflammatory drugs]. Hameeteman W; Dekker W Ned Tijdschr Geneeskd; 1991 Apr; 135(16):723-4. PubMed ID: 2038401 [No Abstract] [Full Text] [Related]
39. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit. Hawkey CJ Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265 [No Abstract] [Full Text] [Related]